Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1167557 Greenwich, CT
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,225,547
+$1,474,205 QoQ
Shares Held
522,749
-1.0% QoQ
Ownership
0.303%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 354 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. ACAD ranks #40 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in ACAD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,225,547 522,749
2026-03-31 $11,751,342 527,913
2025-12-31 $16,152,815 604,748
2025-09-30 $13,248,552 620,832
2025-06-30 $6,292,031 291,703
2025-03-31 $1,124,029 67,672
2024-12-31 $1,196,052 65,180
2024-09-30 $567,951 36,928
2024-06-30 $588,102 36,191
2024-03-31 $879,143 47,547
2023-12-31 $1,541,922 49,247
2023-09-30 $1,002,966 48,127
2023-06-30 $1,106,274 46,191
2023-03-31 $760,064 40,386
2022-12-31 $723,309 45,434
2022-09-30 $652,813 39,903
2022-06-30 $665,949 47,264
2022-03-31 $943,804 38,968
2021-12-31 $646,354 27,693
2021-03-31 $223,453 8,661
2020-12-31 $613,239 11,471
2020-09-30 $875,737 21,230
2020-06-30 $4,844,964 99,958
2020-03-31 $4,726,254 111,864